Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen Axetil Adjuvant for Post-craniotomy Pain
NCT05624359Suspended
- Sponsor
- Beijing Tiantan Hospital
- Start
- Nov 2023
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of flurbiprofen axetil in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Total consumption of sufentanil with PCIA device at 48 hours. Started Nov 2023; status: suspended.
02
Drugs
flurbiprofen axetil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05624359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05624359.